Trials / Completed
CompletedNCT04439643
Plaque Stratification Using Ccta in Coronary ARtery Disease (PoSTCARD)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 800 (actual)
- Sponsor
- Elucid Bioimaging Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Develop time-to-event prediction and plaque phenotype classification models for patients with known or suspected coronary artery disease.
Detailed description
Develop time-to-event prediction and plaque phenotype classification models using plaque morphology and composition assessment of CTA which has been validated by histology, applied to representative cohort of patients. Generalizability of models is enhanced by using validated rather than only raw image inputs. Demographic, clinical, and outcome data is collected for enrolled patients as well as last known well dates.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | vascuCAP | time to event and phenotype classification model |
Timeline
- Start date
- 2020-02-05
- Primary completion
- 2022-02-28
- Completion
- 2022-07-30
- First posted
- 2020-06-19
- Last updated
- 2023-09-13
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04439643. Inclusion in this directory is not an endorsement.